By Tony Fong

NEW YORK (GenomeWeb News) – Sample preparation firm IntegenX today said that it has acquired biosample storage firm GenVault. It also announced it has raised $15.6 million in a financing round.

Stevan Jovanovich, president and CEO of IntegenX, declined to disclose the terms of the deal but said the purchase moves the company further upstream in the sequencing market.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.